Trials / Unknown
UnknownNCT04074369
Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects
Evaluation of CRISPR-based Test for the Rapid Identification of Mycobacterium Tuberculosis Complex in Pulmonary Tuberculosis Suspects
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- Huashan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This observational Mycobacterium tuberculosis (MTB) diagnostics evaluation study is a prospective study of pulmonary TB suspects who are undergoing sputum or bronchoalveolar lavage fluid (BALF) evaluation for pulmonary TB. The sensitivity and specificity of the CRISPR-based assay will be compared to clinical diagnosis, conventional culture methods and Xpert MTB/RIF assay on same batch specimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | CRISPR-based Test | CRISPR-based Test performed on sputum or BALF in TB suspects. |
Timeline
- Start date
- 2019-05-01
- Primary completion
- 2019-10-30
- Completion
- 2019-10-30
- First posted
- 2019-08-30
- Last updated
- 2019-08-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04074369. Inclusion in this directory is not an endorsement.